Zimmer Biomet Holdings Revenue decreased by 7.0% to $2.09B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.3%, from $1.91B to $2.09B. Over 4 years (FY 2021 to FY 2025), Revenue shows an upward trend with a 4.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Growth indicates successful market penetration, pricing power, or volume expansion, while a decline suggests weakening demand or competitive pressure.
This represents the total gross revenue generated from the sale of goods and services to customers, excluding any sales-...
The standard top-line revenue metric used across all public companies for financial reporting.
other_revenue_from_contract_with_customer_excluding_asse_0d5b70| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.76B | $1.69B | $1.78B | $1.66B | $1.78B | $1.67B | $1.83B | $1.83B | $1.87B | $1.75B | $1.94B | $1.89B | $1.94B | $1.82B | $2.02B | $1.91B | $2.08B | $2.00B | $2.24B | $2.09B |
| QoQ Change | — | -4.4% | +5.4% | -6.4% | +7.1% | -6.3% | +9.3% | +0.3% | +2.1% | -6.2% | +10.6% | -2.6% | +2.8% | -6.1% | +10.9% | -5.6% | +8.8% | -3.7% | +12.1% | -7.0% |
| YoY Change | — | — | — | — | +1.0% | -0.9% | +2.7% | +10.1% | +4.9% | +5.0% | +6.3% | +3.2% | +3.9% | +4.0% | +4.3% | +1.1% | +7.0% | +9.7% | +10.9% | +9.3% |